Pfizer CEO and Chairman Albert Bourla on Tuesday announced that the company and its partner BioNTech have submitted a request to the U.S. Food and Drug Administration (FDA) seeking to expand authorization for its COVID-19 booster shot for use in 16- and 17-year-olds. It comes after U.S. regulators last week expanded the eligibility for a…
Pfizer Seeks FDA Authorization for COVID-19 Booster Shots in 16- and 17-Year-Olds
UK Hastens CCP Virus Booster Vaccination to Preempt Possible Omicron Wave
All adults in the UK will be offered another dose of a CCP (Chinese Communist Party) virus vaccine as the government’s immunisation advisory body updated its recommendations on Monday. After 11 cases of the Omicron CCP virus variant were identified in the UK, the Joint Committee on Vaccination and Immunisation (JCVI) urgently expanded the eligibility to receive booster doses…
Health Canada Approves Pfizer Vaccine for Children Aged 5 to 11
Health Canada has announced that the Pfizer-BioNTech COVID-19 vaccine has been approved for children between the ages of 5 and 11, the first vaccine to be used for this age group in the country. Health officials announced the decision in a press conference on Friday, with the specific timeline of the vaccine rollout to be announced…
Health Canada Authorizes Use of Pfizer Vaccine as a Booster Shot
Health Canada has authorized the Pfizer-BioNTech COVID-19 vaccine to be used as a booster shot for adults 18 years-old and above, saying the shot is designed to help people maintain their protection against the virus over time. Health Canada said in a statement Tuesday that it had received a submission from Pfizer on Oct. 1 seeking approval…
Pfizer’s COVID-19 Booster Dose Effective in Preventing Severe Disease: Israeli Study
A booster dose of Pfizer-BioNTech’s COVID-19 vaccine five months after a second shot reduces an individual’s risk of hospitalization by 93 percent, according to an Israeli study published on Thursday. The study, published in The Lancet medical journal (pdf), was conducted by Israel’s largest HMO Clalit Health Services, with funding from Harvard Medical School. Researchers…
California’s Vaccine Mandates Are ‘Medical Tyranny,’ Says Former UCLA Doctor
It is a “violation of ethics” that one physician should decide whether 40 million Americans in California get vaccinated against COVID-19 according to Dr. Christopher Rake, who until recently, was an anesthesiologist at the UCLA Medical Centre. As has been the case with numerous states across America, California’s Department of Public Health (CDPH) issued a mandate in early…
California’s Vaccine Mandates Are ‘Medical Tyranny,’ Says UCLA Doctor
It is a “violation of ethics” that one physician should decide whether 40 million Americans in California get vaccinated against COVID-19 according to Dr. Christopher Rake, an anesthesiologist at the UCLA Medical Center. As has been the case with numerous states across America, California’s Department of Public Health (CDPH) issued a mandate in early August stating that health…
Pfizer Board Member: Potential COVID-19 Vaccine Mandate For Young Children ‘A Long Way Off’
Dr. Scott Gottlieb, former Food and Drug Administration (FDA) commissioner, said on Sunday that he believes a potential COVID-19 vaccine mandate for young children is likely to be “a long way off.” Gottlieb, now a board member for U.S.-based pharmaceutical company Pfizer, said during an appearance on CBS’s “Face the Nation” that such a mandate…
Effectiveness of Pfizer-BioNTech COVID-19 Vaccine Falls Below 50 Percent After 5 Months: Study
The effectiveness of the Pfizer-BioNTech COVID-19 vaccine falls below 50 percent after five months, according to a new study published in The Lancet medical journal on Oct. 4. The study (pdf), which was funded by Pfizer, aimed to evaluate the overall variant-specific effectiveness of the Pfizer-BioNTech vaccine against CCP (Chinese Communist Party) virus infections and COVID-19-related hospital admissions over time….
Effectiveness of Pfizer COVID-19 Vaccine Falls Below 50 Percent After 5 Months: Study
The effectiveness of the Pfizer-BioNTech COVID-19 vaccine falls below 50 percent after five months, according to a new study published in The Lancet medical journal on Oct. 4. The study (pdf), which was funded by Pfizer, aimed to evaluate the overall variant-specific effectiveness of the Pfizer-BioNTech vaccine against CCP (Chinese Communist Party) virus infections and COVID-19-related hospital admissions over time….
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta